Pub Date : 2026-03-11DOI: 10.1016/j.neuron.2026.01.032
Siling Du, Feiya Ou, Antoine Drieu, Eric Z Xu, Yumeng Cheng, Steffen E Storck, Tornike Mamuladze, Jay Cao, Nora Abduljawad, Bishan Bhattarai, Justin Rustenhoven, Niall Mortimer, Simone Brioschi, Khai Nguyen, Patrick Fernandes Rodrigues, Igor Smirnov, Daniel Gibson, J Michael White, Wandy Beatty, David DeNardo, Qingyun Li, Michael Meers, Claudia Z Han, Na Sun, Florent Ginhoux, Marina Cella, Marco Colonna, Jonathan Kipnis
Microglia arise from yolk sac progenitors and are thought to persist throughout life with minimal input from adult hematopoiesis. However, whether brain-engrafted monocyte-derived macrophages (MDMs) exist at homeostasis and during turnover and how they function relative to yolk-sac-derived microglia (YSMs) remain unsettled. Here, we combine lineage tracing, pharmacological microglia depletion, and multi-omics profiling to define the ontogeny, identity, and function of brain parenchymal macrophages. Despite sharing the parenchymal milieu, MDMs display transcriptional and epigenetic landscapes distinct from YSMs. Fate-mapping reveals that brain-engrafted MDMs transiently express CD206, echoing a developmental stage of microglial precursors. MDM engraftment and polarization are modulated by interleukin (IL)-34 and C-C chemokine receptor 2 (CCR2). Furthermore, parabiosis and skull-flap transplantation reveal that both blood and skull marrow supply the niche, yielding origin-biased MDM states. Functionally, MDM engraftment enhances cuprizone-mediated demyelination. Together, our study defines the origins, molecular features, and context-dependent roles of brain parenchymal macrophages across homeostasis, turnover, and central nervous system (CNS) pathology.
{"title":"Brain-engrafted monocyte-derived macrophages from blood and skull-bone marrow exhibit distinct properties.","authors":"Siling Du, Feiya Ou, Antoine Drieu, Eric Z Xu, Yumeng Cheng, Steffen E Storck, Tornike Mamuladze, Jay Cao, Nora Abduljawad, Bishan Bhattarai, Justin Rustenhoven, Niall Mortimer, Simone Brioschi, Khai Nguyen, Patrick Fernandes Rodrigues, Igor Smirnov, Daniel Gibson, J Michael White, Wandy Beatty, David DeNardo, Qingyun Li, Michael Meers, Claudia Z Han, Na Sun, Florent Ginhoux, Marina Cella, Marco Colonna, Jonathan Kipnis","doi":"10.1016/j.neuron.2026.01.032","DOIUrl":"10.1016/j.neuron.2026.01.032","url":null,"abstract":"<p><p>Microglia arise from yolk sac progenitors and are thought to persist throughout life with minimal input from adult hematopoiesis. However, whether brain-engrafted monocyte-derived macrophages (MDMs) exist at homeostasis and during turnover and how they function relative to yolk-sac-derived microglia (YSMs) remain unsettled. Here, we combine lineage tracing, pharmacological microglia depletion, and multi-omics profiling to define the ontogeny, identity, and function of brain parenchymal macrophages. Despite sharing the parenchymal milieu, MDMs display transcriptional and epigenetic landscapes distinct from YSMs. Fate-mapping reveals that brain-engrafted MDMs transiently express CD206, echoing a developmental stage of microglial precursors. MDM engraftment and polarization are modulated by interleukin (IL)-34 and C-C chemokine receptor 2 (CCR2). Furthermore, parabiosis and skull-flap transplantation reveal that both blood and skull marrow supply the niche, yielding origin-biased MDM states. Functionally, MDM engraftment enhances cuprizone-mediated demyelination. Together, our study defines the origins, molecular features, and context-dependent roles of brain parenchymal macrophages across homeostasis, turnover, and central nervous system (CNS) pathology.</p>","PeriodicalId":19313,"journal":{"name":"Neuron","volume":" ","pages":""},"PeriodicalIF":15.0,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147444439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amyotrophic lateral sclerosis (ALS) is genetically and clinically heterogeneous, yet convergent pathogenic mechanisms remain poorly defined. A CRISPR-Cas9 screen identified phosphoglycerate mutase-5 (PGAM5) as a common mediator of ALS pathogenesis. PGAM5 activates the mitochondrial integrated stress response (mtISR) via dephosphorylation of metallopeptidase OMA1 at Ser223 and Ser237, thereby driving neuromuscular junction disruption and motor deficits. We show that PGAM5 is a substrate of valosin-containing protein (VCP) and is consistently elevated in spinal cords from sporadic ALS patients, in human spinal cord organoids derived from sporadic or familial ALS, and in ALS mouse models. The disruption of PGAM5-OMA1 interaction by a selective inhibitor (TAT-PO1) or pharmacological inhibition of PGAM5 with telmisartan suppresses mtISR activation and ameliorates ALS-related phenotypes by reshaping mtISR outputs in a manner distinct from those elicited by activation of translation initiation factor 2B (eIF2B). These findings establish PGAM5 as a convergent and actionable therapeutic target across ALS subtypes.
{"title":"Targeting PGAM5-driven mitochondrial integrated stress response slows ALS progression across subtypes.","authors":"Zhilong Zheng, Wangju Yang, Zhen Chen, Panpan Chen, Mengdan Tao, Shengda Wang, Bowei Cui, Zeyue Yang, Yanqing Yan, Xiao Han, Yongjie Zhang, Zijian Ren, Xiaoxin Yan, Yueqing Jiang, Jing Wang, Tingyou Li, Yan Liu, Xing Guo","doi":"10.1016/j.neuron.2026.02.003","DOIUrl":"https://doi.org/10.1016/j.neuron.2026.02.003","url":null,"abstract":"<p><p>Amyotrophic lateral sclerosis (ALS) is genetically and clinically heterogeneous, yet convergent pathogenic mechanisms remain poorly defined. A CRISPR-Cas9 screen identified phosphoglycerate mutase-5 (PGAM5) as a common mediator of ALS pathogenesis. PGAM5 activates the mitochondrial integrated stress response (mtISR) via dephosphorylation of metallopeptidase OMA1 at Ser223 and Ser237, thereby driving neuromuscular junction disruption and motor deficits. We show that PGAM5 is a substrate of valosin-containing protein (VCP) and is consistently elevated in spinal cords from sporadic ALS patients, in human spinal cord organoids derived from sporadic or familial ALS, and in ALS mouse models. The disruption of PGAM5-OMA1 interaction by a selective inhibitor (TAT-PO1) or pharmacological inhibition of PGAM5 with telmisartan suppresses mtISR activation and ameliorates ALS-related phenotypes by reshaping mtISR outputs in a manner distinct from those elicited by activation of translation initiation factor 2B (eIF2B). These findings establish PGAM5 as a convergent and actionable therapeutic target across ALS subtypes.</p>","PeriodicalId":19313,"journal":{"name":"Neuron","volume":" ","pages":""},"PeriodicalIF":15.0,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147444436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-10DOI: 10.1016/j.neuron.2026.01.026
Rodrigo Quian Quiroga
I discuss human single-neuron recordings and the discovery of concept cells-i.e., neurons representing specific concepts in the hippocampus and surrounding cortex-about 20 years ago. I then present the main properties of concept cells and show how these neurons are involved in forming and storing memories in coordination with complementary neocortical representations. Finally, I compare the response properties of concept cells with those reported in the hippocampus of other species and argue that the abstract representation by concept cells is exclusively human and might be a cornerstone of human cognitive abilities, such as our power for high-level abstract thinking and generalization.
{"title":"20 years of concept cells: From invariant responses to a unique coding of human memory.","authors":"Rodrigo Quian Quiroga","doi":"10.1016/j.neuron.2026.01.026","DOIUrl":"https://doi.org/10.1016/j.neuron.2026.01.026","url":null,"abstract":"<p><p>I discuss human single-neuron recordings and the discovery of concept cells-i.e., neurons representing specific concepts in the hippocampus and surrounding cortex-about 20 years ago. I then present the main properties of concept cells and show how these neurons are involved in forming and storing memories in coordination with complementary neocortical representations. Finally, I compare the response properties of concept cells with those reported in the hippocampus of other species and argue that the abstract representation by concept cells is exclusively human and might be a cornerstone of human cognitive abilities, such as our power for high-level abstract thinking and generalization.</p>","PeriodicalId":19313,"journal":{"name":"Neuron","volume":" ","pages":""},"PeriodicalIF":15.0,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147433655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-10DOI: 10.1016/j.neuron.2026.01.021
Xin-Yu Su, Elizabeth A Ronan, Sienna K Perry, Hankyu Lee, Chia Chun Hor, Mahar Fatima, Xi Yuan Zheng, Jingyao Wang, Siyi Liu, Karin Harumi Uchima Koecklin, Shuhao Wan, Aditi Jha, Peng Li, Wanlu Du, Dawen Cai, Joshua J Emrick, Bo Duan
How hindbrain circuits integrate peripheral and central signals to regulate complex oral behaviors is poorly understood. In rodents, gnawing is essential for localized tooth wear to offset lifelong incisor growth. Whether this process relies on specific sensory input to guide localized tooth wear and is actively regulated by neural mechanisms remains unresolved. Here, we identify somatostatin-expressing neurons in the spinal trigeminal nucleus oralis as a central relay distributing tactile input to motor execution and motivational circuits. These neurons receive input from a genetically distinct population of S100b+ Aβ low-threshold mechanoreceptors that innervate the incisor periodontium and project to both jaw-closing motor neurons and, via the parabrachial nucleus, the ventral tegmental area. Disruption of this pathway abolished gnawing and resulted in severe malocclusion, while activation triggered dopamine release in the nucleus accumbens. Our findings redefine dental alignment as an active, touch-dependent, circuit-governed process and reframe malocclusion as a sensorimotor-motivational integration disorder.
后脑回路如何整合外周和中枢信号来调节复杂的口腔行为尚不清楚。在啮齿类动物中,咀嚼对于局部牙齿磨损是必不可少的,以抵消终身门牙的生长。这一过程是否依赖于特定的感觉输入来指导局部牙齿磨损,并受到神经机制的积极调节,目前尚不清楚。在这里,我们发现在脊髓三叉神经口核中表达生长抑素的神经元是将触觉输入分配到运动执行和动机回路的中央继电器。这些神经元接受来自遗传上不同的S100b+ a β低阈值机械感受器的输入,这些机械感受器支配门牙牙周膜,并投射到下颌闭合运动神经元,并通过臂旁核投射到腹侧被盖区。这一通路的破坏消除了咀嚼并导致严重的错颌,而激活则触发伏隔核释放多巴胺。我们的研究结果将牙齿排列重新定义为一种主动的、依赖触摸的、回路控制的过程,并将错牙合重新定义为一种感觉运动动机整合障碍。
{"title":"A touch-guided neural circuit regulates motivated gnawing to maintain dental alignment.","authors":"Xin-Yu Su, Elizabeth A Ronan, Sienna K Perry, Hankyu Lee, Chia Chun Hor, Mahar Fatima, Xi Yuan Zheng, Jingyao Wang, Siyi Liu, Karin Harumi Uchima Koecklin, Shuhao Wan, Aditi Jha, Peng Li, Wanlu Du, Dawen Cai, Joshua J Emrick, Bo Duan","doi":"10.1016/j.neuron.2026.01.021","DOIUrl":"https://doi.org/10.1016/j.neuron.2026.01.021","url":null,"abstract":"<p><p>How hindbrain circuits integrate peripheral and central signals to regulate complex oral behaviors is poorly understood. In rodents, gnawing is essential for localized tooth wear to offset lifelong incisor growth. Whether this process relies on specific sensory input to guide localized tooth wear and is actively regulated by neural mechanisms remains unresolved. Here, we identify somatostatin-expressing neurons in the spinal trigeminal nucleus oralis as a central relay distributing tactile input to motor execution and motivational circuits. These neurons receive input from a genetically distinct population of S100b<sup>+</sup> Aβ low-threshold mechanoreceptors that innervate the incisor periodontium and project to both jaw-closing motor neurons and, via the parabrachial nucleus, the ventral tegmental area. Disruption of this pathway abolished gnawing and resulted in severe malocclusion, while activation triggered dopamine release in the nucleus accumbens. Our findings redefine dental alignment as an active, touch-dependent, circuit-governed process and reframe malocclusion as a sensorimotor-motivational integration disorder.</p>","PeriodicalId":19313,"journal":{"name":"Neuron","volume":" ","pages":""},"PeriodicalIF":15.0,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147434053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-10DOI: 10.1016/j.neuron.2026.01.022
Adam Turnbull, James J Gross, Feng Vankee-Lin
Preclinical Alzheimer's disease (AD) is associated with distressing neuropsychiatric symptoms (NPSs) that may accelerate progression toward dementia. Existing approaches probe the symptom-level domain-general or domain-specific neural correlates of NPSs. However, the field lacks process-oriented models of symptom emergence for targeted treatment. We propose one pathway for symptom emergence involving the disruption of emotion regulation (ER) systems by early AD pathology. AD pathology in the ventral anterior cingulate cortex-ventromedial prefrontal cortex disrupts model-free ER that modulates negative valuations using experience-dependent reinforcement learning (e.g., fear extinction), leading to increased negative valuations and negative affect. We further propose that model-based ER competes for overtaxed executive resources and is less successful in preclinical AD, particularly in demanding real-world contexts. These changes lead to a shift toward negative affect, leading to divergent trajectories of NPSs depending on critical moderators. We discuss implications for intervention to improve NPSs and potentially slow dementia progression.
{"title":"The emergence of neuropsychiatric symptoms in preclinical Alzheimer's disease: An emotion regulation perspective.","authors":"Adam Turnbull, James J Gross, Feng Vankee-Lin","doi":"10.1016/j.neuron.2026.01.022","DOIUrl":"10.1016/j.neuron.2026.01.022","url":null,"abstract":"<p><p>Preclinical Alzheimer's disease (AD) is associated with distressing neuropsychiatric symptoms (NPSs) that may accelerate progression toward dementia. Existing approaches probe the symptom-level domain-general or domain-specific neural correlates of NPSs. However, the field lacks process-oriented models of symptom emergence for targeted treatment. We propose one pathway for symptom emergence involving the disruption of emotion regulation (ER) systems by early AD pathology. AD pathology in the ventral anterior cingulate cortex-ventromedial prefrontal cortex disrupts model-free ER that modulates negative valuations using experience-dependent reinforcement learning (e.g., fear extinction), leading to increased negative valuations and negative affect. We further propose that model-based ER competes for overtaxed executive resources and is less successful in preclinical AD, particularly in demanding real-world contexts. These changes lead to a shift toward negative affect, leading to divergent trajectories of NPSs depending on critical moderators. We discuss implications for intervention to improve NPSs and potentially slow dementia progression.</p>","PeriodicalId":19313,"journal":{"name":"Neuron","volume":" ","pages":""},"PeriodicalIF":15.0,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13007717/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147434476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-09DOI: 10.1016/j.neuron.2026.01.018
Yingzhi Ye, Zhe Zhang, Yu Xiao, Chengzhang Zhu, Noelle Wright, Julie Asbury, Yongxin Huang, Weiren Wang, Laura Gomez-Isaza, Juan C. Troncoso, Chuan He, Shuying Sun
The proteinopathy of the RNA-binding protein TDP-43, characterized by nuclear clearance and cytoplasmic inclusion, is a hallmark of multiple neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer’s disease (AD). Through CRISPR interference (CRISPRi) screening in human neurons, we identified the decapping scavenger enzyme (DCPS) as a novel genetic modifier of TDP-43 loss-of-function (LOF)-mediated neurotoxicity. Our findings reveal that TDP-43 LOF leads to aberrant mRNA degradation via dysregulating the properties and activity of processing bodies (P-bodies). TDP-43 interacts with P-body component proteins, potentially influencing their dynamic equilibrium and assembly into ribonucleoprotein (RNP) granules. Loss of TDP-43 hyperactivates P-bodies, increasing mRNA association and RNA decay. Reducing DCPS restores P-body integrity and RNA turnover, ultimately improving neuronal survival. Overall, this study highlights a novel role of TDP-43 in RNA processing through P-body regulation and identifies DCPS as a potential therapeutic target for TDP-43 proteinopathy-related neurodegenerative diseases.
{"title":"DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay","authors":"Yingzhi Ye, Zhe Zhang, Yu Xiao, Chengzhang Zhu, Noelle Wright, Julie Asbury, Yongxin Huang, Weiren Wang, Laura Gomez-Isaza, Juan C. Troncoso, Chuan He, Shuying Sun","doi":"10.1016/j.neuron.2026.01.018","DOIUrl":"https://doi.org/10.1016/j.neuron.2026.01.018","url":null,"abstract":"The proteinopathy of the RNA-binding protein TDP-43, characterized by nuclear clearance and cytoplasmic inclusion, is a hallmark of multiple neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer’s disease (AD). Through CRISPR interference (CRISPRi) screening in human neurons, we identified the decapping scavenger enzyme (DCPS) as a novel genetic modifier of TDP-43 loss-of-function (LOF)-mediated neurotoxicity. Our findings reveal that TDP-43 LOF leads to aberrant mRNA degradation via dysregulating the properties and activity of processing bodies (P-bodies). TDP-43 interacts with P-body component proteins, potentially influencing their dynamic equilibrium and assembly into ribonucleoprotein (RNP) granules. Loss of TDP-43 hyperactivates P-bodies, increasing mRNA association and RNA decay. Reducing DCPS restores P-body integrity and RNA turnover, ultimately improving neuronal survival. Overall, this study highlights a novel role of TDP-43 in RNA processing through P-body regulation and identifies DCPS as a potential therapeutic target for TDP-43 proteinopathy-related neurodegenerative diseases.","PeriodicalId":19313,"journal":{"name":"Neuron","volume":"8 1","pages":""},"PeriodicalIF":16.2,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147392638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-06DOI: 10.1016/j.neuron.2025.12.047
Louis Pezon, Valentin Schmutz, Wulfram Gerstner
Dimensionality reduction methods are widely used in neuroscience to investigate two complementary aspects of neural activity: the distribution of single-neuron functional properties and the low-dimensional collective dynamics of population activity. However, how do these two aspects of neural activity relate to the structure of the underlying neural circuit? In this work, we connect circuit structure, single-neuron functional properties, and emerging low-dimensional dynamics in spiking recurrent network models. Our models explain how topologically distinct circuit structures can produce equivalent low-dimensional dynamics. Despite this degeneracy, we find that circuit structure imposes specific constraints on both the low-dimensional dynamics of population activity and the distribution of single-neuron functional properties. These constraints yield simple criteria for comparing network models with observed neural activity. Our modeling framework not only links classical models of cortical circuits to the more recent notion of neural manifolds but also paves the way for designing tractable models of population dynamics that are better aligned with neural recordings.
{"title":"Linking neural manifolds to circuit structure in recurrent networks.","authors":"Louis Pezon, Valentin Schmutz, Wulfram Gerstner","doi":"10.1016/j.neuron.2025.12.047","DOIUrl":"https://doi.org/10.1016/j.neuron.2025.12.047","url":null,"abstract":"<p><p>Dimensionality reduction methods are widely used in neuroscience to investigate two complementary aspects of neural activity: the distribution of single-neuron functional properties and the low-dimensional collective dynamics of population activity. However, how do these two aspects of neural activity relate to the structure of the underlying neural circuit? In this work, we connect circuit structure, single-neuron functional properties, and emerging low-dimensional dynamics in spiking recurrent network models. Our models explain how topologically distinct circuit structures can produce equivalent low-dimensional dynamics. Despite this degeneracy, we find that circuit structure imposes specific constraints on both the low-dimensional dynamics of population activity and the distribution of single-neuron functional properties. These constraints yield simple criteria for comparing network models with observed neural activity. Our modeling framework not only links classical models of cortical circuits to the more recent notion of neural manifolds but also paves the way for designing tractable models of population dynamics that are better aligned with neural recordings.</p>","PeriodicalId":19313,"journal":{"name":"Neuron","volume":" ","pages":""},"PeriodicalIF":15.0,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147372982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anxiety disorders are the most prevalent mental disorders globally, yet current treatments remain limited. Histamine is an evolutionarily conserved neuromodulator recently implicated in neuropsychiatric disorders. However, whether and how histaminergic signaling dynamically represents emotionally salient information and regulates anxiety remain largely unknown. We show that anxiogenic exposure triggers region-specific dynamic histamine release in ventral hippocampal CA1 (vCA1). The vCA1-projecting histaminergic circuit exhibits similar dynamics and bidirectionally regulates anxiety through engaging astrocytic H3 receptors (H3Rs). Genetic ablation of astrocytic H3Rs attenuates astrocytic responsiveness to anxiety-related contexts and directly promotes anxiety via gliotransmitter γ-aminobutyric acid (GABA) signaling. Notably, chronic stress induces adaptive upregulation of vCA1 astrocytic H3R expression, while further potentiation of astrocytic H3R signaling is sufficient to attenuate maladaptive anxiety. These findings collectively establish that vCA1 astrocytic histaminergic signaling governs natural anxiolysis in both normal and maladaptive anxiety states, identifying astrocytic H3Rs as crucial emotional regulators and a potential therapeutic target for anxiety disorders.
{"title":"Astrocytic H3 receptors regulate anxiety through GABA signaling.","authors":"Yulan Li, Yibei Wang, Lixuan Li, Xinyi Li, Xiaopeng Ding, Wenkai Lin, Jing Xi, Yuying Shao, Heming Cheng, Shumin Duan, Vladimir Parpura, Yi Wang, Zhong Chen","doi":"10.1016/j.neuron.2026.01.020","DOIUrl":"https://doi.org/10.1016/j.neuron.2026.01.020","url":null,"abstract":"<p><p>Anxiety disorders are the most prevalent mental disorders globally, yet current treatments remain limited. Histamine is an evolutionarily conserved neuromodulator recently implicated in neuropsychiatric disorders. However, whether and how histaminergic signaling dynamically represents emotionally salient information and regulates anxiety remain largely unknown. We show that anxiogenic exposure triggers region-specific dynamic histamine release in ventral hippocampal CA1 (vCA1). The vCA1-projecting histaminergic circuit exhibits similar dynamics and bidirectionally regulates anxiety through engaging astrocytic H3 receptors (H3Rs). Genetic ablation of astrocytic H3Rs attenuates astrocytic responsiveness to anxiety-related contexts and directly promotes anxiety via gliotransmitter γ-aminobutyric acid (GABA) signaling. Notably, chronic stress induces adaptive upregulation of vCA1 astrocytic H3R expression, while further potentiation of astrocytic H3R signaling is sufficient to attenuate maladaptive anxiety. These findings collectively establish that vCA1 astrocytic histaminergic signaling governs natural anxiolysis in both normal and maladaptive anxiety states, identifying astrocytic H3Rs as crucial emotional regulators and a potential therapeutic target for anxiety disorders.</p>","PeriodicalId":19313,"journal":{"name":"Neuron","volume":" ","pages":""},"PeriodicalIF":15.0,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147369896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-05DOI: 10.1016/j.neuron.2026.02.016
David Sussillo
In this interview with Neuron, David Sussillo reflects on his journey from a disadvantaged childhood to becoming a leading computational neuroscientist and AI researcher. He discusses the development of FORCE learning, advances in neural network interpretability, the interplay between academia and industry, and advice for aspiring scientists from non-traditional backgrounds.
{"title":"David Sussillo.","authors":"David Sussillo","doi":"10.1016/j.neuron.2026.02.016","DOIUrl":"https://doi.org/10.1016/j.neuron.2026.02.016","url":null,"abstract":"<p><p>In this interview with Neuron, David Sussillo reflects on his journey from a disadvantaged childhood to becoming a leading computational neuroscientist and AI researcher. He discusses the development of FORCE learning, advances in neural network interpretability, the interplay between academia and industry, and advice for aspiring scientists from non-traditional backgrounds.</p>","PeriodicalId":19313,"journal":{"name":"Neuron","volume":" ","pages":""},"PeriodicalIF":15.0,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147369908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-04DOI: 10.1016/j.neuron.2026.01.008
Dong Dong, Longzhen Cheng
Why do opioid responses vary greatly among individuals? Leduc-Pessah et al.1 show that the Runx1 transcription factor is a genetic determinant of opioid analgesia and adverse effects across species, presumably operating by governing microglial reactivity.
{"title":"A genetic architect of opioid responses: Microglial Runx1","authors":"Dong Dong, Longzhen Cheng","doi":"10.1016/j.neuron.2026.01.008","DOIUrl":"https://doi.org/10.1016/j.neuron.2026.01.008","url":null,"abstract":"Why do opioid responses vary greatly among individuals? Leduc-Pessah et al.1 show that the Runx1 transcription factor is a genetic determinant of opioid analgesia and adverse effects across species, presumably operating by governing microglial reactivity.","PeriodicalId":19313,"journal":{"name":"Neuron","volume":"406 1","pages":"795-797"},"PeriodicalIF":16.2,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147359504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}